| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Sanka Murali Krishna Murthy CEO | XNSE Exchange | Y6495A125 CUSIP |
| India Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Ortin Global Limited, previously known as Ortin Laboratories Limited until June 2024, is a firm rooted in the pharmaceutical sector based in Hyderabad, India. Founded in 1986, the company has built its repute in the manufacture and trading of pharmaceuticals, drugs, and intermediates. It extends its offerings across India, focusing on the development, production, and distribution of a wide array of pharmaceutical formulations and active pharmaceutical ingredient (API) intermediates, as well as fine chemicals. Ortin Global is also engaged in providing a spectrum of services that encompass process development, analytical research, and diagnostic solutions. Beyond its manufacturing capabilities, it acts as a merchant exporter of pharmaceutical finished formulations, while also engaging in long-term contracts for the development of new APIs and the manufacturing of intermediates.